KBF1 (p50 NF-κB homodimer) .Acts as a repressor of H-2Kb gene expression in metastatic tumor cells

Journal of Experimental Medicine

Volumn 177, Issue 6, 1993, Pages 1651-1662

  Plaksin, Daniel ^a   Baeuerle, Patrick A ^b   Eisenbach, Lea ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEAR FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LEWIS CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; TUMOR CELL;

ANIMAL; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; H-2 ANTIGENS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0027190466     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.6.1651     Document Type: Article

References (85)

1. Maryanski, J.L., P. Pala, G. Corradin, B.R. Jordan, and J.C. Cerrotini. 1986. H-2 restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptides. Nature (Lond.). 324:578.
2. Townsend, A., J. Rothbard, F. Gotch, G. Bahadur, D. Wraith, and J. McMichael. 1986. The epitopes of influenza nucleopro-tein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
3. Isakov, N., S. Katzav, M. Feldman, and S. Segal. 1983. Loss of expression of transplantation antigens encoded by the H-2 locus on Lewis lung carcinoma cells and its relevance to the tumor’s metastatic properties. J. Natl. Cancer Inst. 71:139.
4. Eisenbach, L., S. Segal, and M. Feldman. 1983. MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int. J. Cancer. 32:113.
5. De Batselier, P., S. Katzav, E. Gorelik, M. Feldman, and S. Segal. 1980. Differential expression of H-2 gene products of tumor cells in tumor cells is associated with their metasto-genic properties. Nature (Land.). 288:179.
6. Bernards, R., P.I. Schrier, A. Houweling, J. Bos, A.J. Van der Eb, M. Zijlstra, and C.J.M. Melief. 1983. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (Land.). 305:776.
7. Schrier, P.I., R. Bernards, R. Vaesson, A. Houweling, and A.J. Van der Eb. 1983. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (Lond.). 305:771.
8. Schmidt, W., and H. Festenstein. 1982. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia. Immunogenetics. 16:257.
9. Doyle, A., W. Martin, K. Funa, A. Gazdar, O. Carney, E. Martin, I. Linnoila, F.F. Cuttitta, J. Mushein, P. Brun, and L. Minna. 1985. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small cell lung cancer. J. Exp. Med. 161:1135.
10. Lampson, A.L., C.A. Fisher, and J. Whelan. 1983. Striking paucity of HLA-A, B, C and β2-microglobulin on human neuroblastoma cell lines. J. Immunol 130:2471.
11. Holden, C.A., A.R. Sanderson, and D. MacDonald. 1983. Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies. J. Am. Acad. Dermatol. 9:867.
12. Sanderson, A.R., and P.C.L. Beverly. 1983. Interferon, β2-microglobulin and immunoselection in the pathway to malignancy. Immunol. Today. 4:211.
13. Masucci, M.G., S. Torsteinsdotter, J. Colombani, E. Klein, and G. Klein. 1987. Down regulation of class I HLA antigens of the Epstein Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl. Acad. Set. USA. 84:4567.
14. Cordon-Cardo, C., Z. Fuks, M. Drobnjak, C. Moreno, L. Eisenbach, and M. Feldman. 1991. Expression of HLA-A, B, C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res. 51:6372.
15. Eisenbach, L., N. Hollander, L. Greenfeld, H. Yakor, S. Segal, and M. Feldman. 1984. The differential expression of H-2K versus H-2D antigens distinguishing low-metastatic from high metastatic clones is correlated with the immunogenic properties of the tumor cells. Int. J. Cancer. 34:567.
16. b gene transfer into high metastatic D122 cells results in tumor rejection in allogeneic recipients, but does not affect metastasis in syngeneic recipients. Implications to mechanisms of allorejec-tion. Int. J. Cancer. 52:771.
17. Eisenbach, L., and M. Feldman. 1985. Genes and antigens controlling tumor metastases. In Hematology and Blood Transfusion: Modem Trends in Human Leukemia IV. Vol. 29. R. Neth, R. Gallo, M. Greaves, and A. Jenkins, editors, Springer-Verlag, Berlin. 449-507.
18. Eisenbach, L., N. Hollander, S. Segal, and M. Feldman. 1985 The differential expression of class I MHC antigens controls the metastatic properties of tumor cells. Transplant. Proc. 17:729.
19. Eisenbach, L., S. Katzav, and M. Feldman. 1986. Im-munomodulation of tumor metastases. In New Experimental Modalities in the Control of Neoplasia. P. Chandra, editor. Plenum Publishing Corporation. New York. 57-70.
20. Eisenbach, L., G. Kushtai, D. Plaksin, and M. Feldman. 1986. MHC genes and oncogenes controlling the metastatic phenotype of tumor cells. Cancer. Rev. 5:1.
21. b gene. Proc Natl. Acad. Sci. USA. 85:4463.
22. van Bleek, G.M., and S.G. Nathenson. 1992. Presentation of antigenic peptides by MHC class I molecules. Trends Cell Biol. 2:202.
23. Braciale, T.J., and V.L. Braciale 1991. Antigen presentation: structural themes and functional variations. Immunol. Today. 12:124.
24. Korber, B., N. Mermod, L. Hood, and I. Stroynowsky. 1988. Regulation of gene expression by interferons: control of H-2 promoter responses. Science (Wash. DC). 239:1302.
25. b promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell. 44:261.
26. Israel, A., A. Kimura, A. Fournier, M. Fellous, and P. Kourilsky. 1986. Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (Lond.). 322:743.
27. Yano, O., J. Kannellopoulos, M. Kieran, O. Le Bail, A. Israel, and P. Kourilsky. 1987. Purification of KBF1, a common factor binding to both H-2 and /32-microglobulin enhancers. EMBO (Eur. Mol. Biol. Organ.) J. 6:3317.
28. Israel, A., O. Yano, F. Logeat, M. Kieran, and P. Kourilsky. 1989. Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells. Nucleic Acids Res. 17:5245.
29. b enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO (Eur. Mol. Biol. Organ.) J. 8:4205.
30. Macchi, M., J.M. Bornert, I. Davidson, M. Kanno, R. Rosales, M. Vigneron, J.H. Xiao, C. Fromental, and P. Chambon. 1989. The SV40 TC-II(xB) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines. EMBO (Eur. Mol. Biol. Organ.) J. 8:4215.
31. Singh, H., J.H. LeBowitz, A.S. Baldwin, and P.A. Sharp. 1988. Molecular cloning of an enhancer binding protein: isolation by screening of and expression library with a recognition site DNA. Cell. 52:415.
32. bml class I MHC gene. EMBO (Eur. Mol. Biol. Organ.) J. 9:127.
33. Hamada, K., S.L. Gleason, B.Z. Levi, S. Hirschfeld, E. Appella, and K. Ozato. 1989. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc. Natl. Acad. Sci. USA. 86:8289.
34. Korber, B., L. Hood, and I. Stroynowski. 1987. Regulation of murine class I genes by interferons is controlled by regions located both 5’ and 3' to the transcription initiation site. Proc. Natl. Acad. Sci. USA. 84:3380.
35. Israel, A., A. Kimura, M. Kieran, O. Yano, J. Kanellopoulos, O. Le Bail, and P. Kourilsky. 1987. A common positive transacting factor binds to enhancer sequences in the promoters of mouse H-2 and /32-microglobulin genes. Proc. Natl. Acad. Sci. USA. 84:2653.
36. Israel, A., O. Le Bail, D. Hatat, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NFxB-like enhancer binding activity which displaces constitutive factors. EMBO (Eur. Mol. Biol. Organ.) J. 8:3793.
37. Baldwin, A.S., and P.A. Sharp. 1988. Two transcription factors, NF-κB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc Natl. Acad. Sci. USA. 85:723.
38. Baeuerle, P.A., and D. Baltimore. 1989. A 65-kD subunit of active NF-xB is required for inhibition of NF-xB by IxB. Genes & Dev. 3:1689.
39. Urban, M.B., R. Schreck, and P. A. Bauerle 1991. NF-xB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO (Eur. Mol. Biol. Organ.) J. 10:1817.
40. Nolan, G.P., S. Ghosh, H.C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell. 64:961.
41. Baeuerle, P.A., and D. Baltimore. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (Wash. DC). 242:540.
42. Baeuerle, P.A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta. 1072:63.
43. Blank, V., P. Kourilsky, and A. Israel. 1992. NF-kappa B and related proteins: rel/dorsal homologies meet ankyrin-like repeats. Trends Biochetn. Sci. 17:135.
44. Kieran, M., V. Blank, F. Logeat, J. Vandekerchkhove, F. Lott-speich, O. Le Bail, P.A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1007.
45. Ghosh, S., A.M. Gifford, L.R. Riviere, P. Tempst, G.P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell. 62:1019.
46. Urban, M.B., and P.A. Baeuerle. 1991. The role of the p50 and p65 subunits of NF-xB in the recognition of cognate sequences. New Biol. 3:279.
47. Liou, H.C., G.P. Nolan, S. Ghosh, T. Fujita, and D. Baltimore. 1992. The NF-κB p50 precursor, pl05, contains an internal IxB-like inhibitor that preferentially inhibits p50. EMBO (Eur. Mol. Biol. Organ.) J. 11:3003.
48. Henkel, T., U. Zabel, K. van Zee, J.M. Muller, E. Fanning, and P.A. Baeuerle. 1992. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell. 68:1121.
49. Inoue, J., L.D. Kerr, A. Kakizuka, and I.M. Verma. 1992. IκBγ, a 70 kd protein identical to the c-terminal half of p110 NF-κB: a new member of the IκB family. Cell. 68:1109.
50. Burke, P.A., S. Hirschfeld, Y. Shirayoshi, J.W. Kasik, K. Hamada, E. Apella, and K. Ozato. 1989. Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J. Exp Med. 169:1309.
51. Zachow, K.R., and H.T. Orr. 1989. Regulation of HLA class I transcription in T cells. J. Immunol. 143:3385.
52. b class I major histocompatibility gene. Mol. Cell. Biol. 7:305.
53. Schmitz, M.L., and P.A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NFκB. EMBO (Eur. Mol. Biol. Organ.) J. 10:3805.
54. Schmid, R.M., N.D. Perkins, C.S. Duckett, P.C. Andrews, and G.J. Nabel. 1991. Cloning of an NF-xB subunit which stimulates HIV transcription in synergy with p65. Nature (Lond.). 352:733.
55. + T lymphocytes. Science (Wash. DC). 256:1452.
56. Fujita, T., G.P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes & Dev. 6:775.
57. Kretzschmar, M., M. Meisterernst, C. Scheidereit, G. Li, and R.G. Roeder. 1992. Transcriptional regulation of the HIV-1 promoter by NFkB in vitro. Genes & Dev. 6:761.
58. Chirgwin, J.M., A.G. Przyblya, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294.
59. Ruben, S.M., P.J. Dillon, R. Schreck, T. Henkel, C. Chen-Hwa, M. Maher, P.A. Baeurele, and C.A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NFkB. Science (Wash. DC). 251:1490.
60. Nudel, U., R. Zakut, M. Shani, S. Neuman, Z. Levi, and D. Yaffe. 1983. The nucleotide sequence of the rat cytoplasmic β actin gene. Nucleic Acids Res. 11:1759.
61. b gene promoter in embryonal carcinoma cells. Immunogenetics. 21:601.
62. Zabel, U., T. Henkel, M. dos Santos Silva, and P.A. Baeuerle. 1993. Nuclear uptake control of NF-κB by MAD-3, an IkB protein present in the nucleus. EMBO (Eur. Mol. Biol. Organ.) J. 12:201.
63. b haplotypes reveal genetic control of isotype expression. J. Immunol. 126:317.
64. Schiile, R., M. Muller, C. Kaltschmidt, and R. Renkawitz. 1988. Many transcription factors interact synergistically with steroid receptors. Science (Wash. DC). 242:1418.
65. Nielsen, D.A., J. Chou, A.J. Mackrell, M.J. Casabadan, and D.F. Steiner. 1983. Expression of a preinsulin β-galactosidase gene fusion in mammalian cells. Proc. Natl. Acad. Sci. USA. 80:5198.
66. Schreiber, E., P. Matthias, M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with ‘miniextracts’, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
67. Haskill, S., A.A. Beg, S.M. Tompkins, J.S. Morris, A.D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and J.A.S. Baldwin. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes I/cB-like activity. Cell. 65:1281.
68. Ten, R.M., C.V. Paya, N. Israel, O. Le Bail, M.G. Mattei, J.L. Virelizier, P. Kourilsky, and A. Israel. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-kB indicates that it participates in its own regulation. EMBO (Eur. Mol. Biol. Organ.) J. 11:195.
69. Maschek, U., W. Pulm, S. Segal, and G.J. Hammerling. 1989. Major hisotocompatibility complex class I genes in murine fibrosarcoma IC9 are down regulated at the level of the chromatin structure. Mol. Cell. Biol. 9:3136.
70. b gene isolated from non-expressing ter-atocarcinoma cells. EMBO (Eur. Mol. Biol. Organ.) J. 3:597.
71. Nagata, T., J.H. Segars, B.Z. Levi, and K. Ozato. 1992. Retinoic acid-dependent transactivation of major histocompatibility complex class I promoters by the nuclear hormone receptor H-2RIIBP in undifferentiated embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA. 89:937.
72. Kushtai, G., J. Barzilay, M. Feldman, and L. Eisenbach. 1988. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes. Oncogene. 2:119.
73. Kushtai, G., M. Feldman, and L. Eisenbach. 1990. c-fos Transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence. Int. J. Cancer. 45:1131.
74. Blanchet, O., J.F. Bourge, H. Zinszner, Z. Tatari, L. Degos, and P. Paul. 1991. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines. Int. J. Cancer. 6:138.
75. Henseling, U., W. Schmidt, H.R. Scholer, P. Grass, and A.K. Hatzopoulos. 1990. A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes. Mol. Cell Biol. 10:4100.
76. Blanchet, O., J.F. Bourge, H. Zinszner, A. Israel, P. Kourilsky, J. Dausset, L. Degos, and P. Paul. 1992. Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression. Proc. Natl. Acad. Sci. USA. 89:3488.
77. Collart, M.A., P.A. Baeuerle, and P. Vassali. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four xB-like motifs and constitutive and inducible forms of NF-kB. Mol. Cell. Biol. 10:1498.
78. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. SiebenUst. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature (Lond.). 359:339.
79. Hemar, A., P. Barrand, M. Ferrer, V. Cornet, G. Buttin, and A. Dautry-Varsat. 1991. Activity of the kB enhancer of the interleukin-2 receptor a chain in somatic cell hybrids is accompanied by the nuclear localization of NF-κB. New Biol. 3:1097.
80. 1 loci. J. Immunol. 139:3878.
81. Natali, P.G., M.R. Nicotra, A. Bigotti, I. Venturo, L. Marcenara, P. Giacomini, and C. Russo. 1989. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. USA. 86:6719.
82. Rees, B.C., A.M. Buckle, K. Gelsthorpe, V. Janes, C.W. Potter, K. Roger, and G. Jacob. 1988. Loss polymorphic A and B locus HLA antigens in colon carcinoma. Br. J. Cancer. 57:374.
83. Smith, M.E.F., W.F. Bodmer, and J.G. Bodmer. 1988. Selective loss of HLA-A, B, C locus products in colorectal adenocarcinoma. Lancet. 8589:824
84. Momburg, F., A. Ziegler, J. Harpecht, P. Moller, G. Moldenhauer, and G.J Hammerling. 1989. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J. Immunol. 142:352.
85. Lopez-Nevot, M.A., F. Esteban, A. Ferrone, J. Gutierrez, M.R. Oliva, C. Romero, C. Huelin, F. Ruiz-Cabello, and F. Garrido. 1989. HLA class I gene expression on human primary tumors and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br. J. Cancer. 59:221.